Liesly Lee

2075 Bayview Avenue
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Demographic and clinical characteristics of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder in Canadian adults.

Demographic and clinical characteristics of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder in Canadian adults.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: January 30, 2026

Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS.

Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS.

Journal: Multiple sclerosis and related disorders
Published: August 14, 2025

Accuracy of Clinical Assessments with Virtual Care in Outpatient Neurological Setting.

Accuracy of Clinical Assessments with Virtual Care in Outpatient Neurological Setting.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: April 07, 2025

Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack.

Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 11, 2024

Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD.

Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 05, 2024

Comparison of vision-related quality of life in NMOSD and MOGAD.

Comparison of vision-related quality of life in NMOSD and MOGAD.

Journal: Multiple sclerosis and related disorders
Published: August 15, 2024

Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.

Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: May 22, 2024

Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health.

Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health.

Journal: Multiple sclerosis and related disorders
Published: September 03, 2023

A Canadian case control study investigating demographic and environmental factors associated with MOGAD.

A Canadian case control study investigating demographic and environmental factors associated with MOGAD.

Journal: Multiple sclerosis and related disorders
Published: July 11, 2023

A national case-control study investigating demographic and environmental factors associated with NMOSD.

A national case-control study investigating demographic and environmental factors associated with NMOSD.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 21, 2023

Evaluation of ethnicity as a predictor of diagnostic phenotype and prognosis in neuromyelitis optica spectrum disorder in Toronto, Canada.

Evaluation of ethnicity as a predictor of diagnostic phenotype and prognosis in neuromyelitis optica spectrum disorder in Toronto, Canada.

Journal: Multiple sclerosis and related disorders
Published: November 19, 2019

Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis.

Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis.

Journal: Multiple sclerosis and related disorders
Published: November 03, 2019
Showing 1-12 of 26

Last Updated: 09/26/2026